855EGP
- Active ingredient
- insulin glulisine human
- Strength
- 100i.u./ml
- Form
- vial
- Manufacturer
- sanofi
- Route
- injection
Uses
Rapid-acting insulin analogue used to improve glycemic control in patients with diabetes mellitus.
Do not use if
Episodes of hypoglycemia and hypersensitivity to insulin glulisine or formulation components.
Side effects
Common adverse effects include hypoglycemia, injection-site reactions, and hypokalemia.
Warnings
Monitor blood glucose closely and use caution when changing insulin regimens.
How it works
Promotes cellular glucose uptake and suppresses hepatic glucose output, lowering blood glucose levels.
Storage
Store refrigerated before use and according to manufacturer recommendations after opening.
